A case report of exacerbation of extrapyramidal symptoms following the switch from risperidone to paliperidone during valproate therapy

A case report of exacerbation of extrapyramidal symptoms following the switch from risperidone to paliperidone during valproate therapy

Abstract Background Paliperidone is a second-generation antipsychotic and the main active metabolite of risperidone, formulated to provide consistent therapeutic effects through an extended-release system, designed to provide consistent therapeutic effects through an extended-release formulation. Wh...

Full description

Saved in:
Bibliographic Details
Main Authors: Emi Hata, Masatoshi Miyauchi, Nobuhiko Noguchi, Takeshi Asami
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Psychiatry
Subjects:
Paliperidone
Risperidone
Valproate
Extrapyramidal Symptoms
Antipsychotic Switching
Neuroleptic Malignant Syndrome
Online Access:https://doi.org/10.1186/s12888-024-06456-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12888-024-06456-x

Similar Items